Patients
If you or someone you care about has been diagnosed with cancer, you may have many questions and concerns. We encourage you to visit the following sites for support and information for people living with cancer, their caregivers, family and friends.
www.ontariocancertrials.ca (list of clinical studies in Ontario, Canada)
www.clinicaltrials.gov (list of clinical studies in the US)
For information about YM BioSciences' products and ongoing clinical studies, please click the appropriate link below.
-
Indication: Cancer
-
Monoclonal antibody
-
Ongoing clinical studies for lung cancer, pediatric and adult brain cancer, esophageal cancer, pancreatic cancer, prostate cancer, gastric cancer, cervical cancer, hepatic carcinoma and breast cancer
-
Approved for sale in certain countries
- Indication: Hematological disorders known as myeloproliferative neoplasms (MPNs), also known as myeloproliferative disorders
- JAK 1/2 small molecule inhibitor
- Ongoing Phase I/II clinical study
- Indication: Cancer
- Vascular Disrupting Agent (VDA)
- Ongoing Phase I/II clinical study
-
Indication: Moderate to severe acute pain
-
Inhaled-delivery composition of free and liposome-encapsulated fentanyl
-
Phase II clinical studies completed
-
Phase III clinical studies planned